BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saberi B, Naik H, Overbey JR, Erwin AL, Anderson KE, Bissell DM, Bonkovsky HL, Phillips JD, Wang B, K Singal A, M McGuire B, Desnick RJ, Balwani M. Hepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the U.S. Porphyrias Consortium. Hepatology 2021;73:1736-46. [PMID: 32681675 DOI: 10.1002/hep.31460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Baumann K, Kauppinen R. Long-term follow-up of acute porphyria in female patients: Update of clinical outcome and life expectancy. Molecular Genetics and Metabolism Reports 2022;30:100842. [DOI: 10.1016/j.ymgmr.2022.100842] [Reference Citation Analysis]
2 Jerves T, Blau N, Ferreira CR. Clinical and biochemical footprints of inherited metabolic diseases. VIII. Neoplasias. Molecular Genetics and Metabolism 2022. [DOI: 10.1016/j.ymgme.2022.03.011] [Reference Citation Analysis]
3 Buendía-Martínez J, Barreda-Sánchez M, Rodríguez-Peña L, Ballesta-Martínez MJ, López-González V, Sánchez-Soler MJ, Serrano-Antón AT, Pérez-Tomás ME, Gil-Ferrer R, Avilés-Plaza F, Glover-López G, Carazo-Díaz C, Guillén-Navarro E. Health impact of acute intermittent porphyria in latent and non-recurrent attacks patients. Orphanet J Rare Dis 2021;16:106. [PMID: 33639982 DOI: 10.1186/s13023-021-01742-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Erwin AL, Balwani M. Porphyrias in the Age of Targeted Therapies. Diagnostics (Basel) 2021;11:1795. [PMID: 34679493 DOI: 10.3390/diagnostics11101795] [Reference Citation Analysis]
5 Moghe A, Anderson KE. Expanding Experience With Liver Transplantation in Acute Intermittent Porphyria. Liver Transpl 2021;27:477-8. [PMID: 33369869 DOI: 10.1002/lt.25979] [Reference Citation Analysis]